Literature DB >> 10695005

Medical therapy. Management of the refractory patient.

J G Hatlebakk1, P O Katz, D O Castell.   

Abstract

Although relatively rare, GERD patients refractory to medical therapy remain a challenge for the clinician. Refractoriness can be diagnosed only if the patient is properly studied on medication and if what should be adequate medical therapy has been given a sufficient therapeutic trial. Use of 24-hour intragastric and intraesophageal pH-metry has improved the ability to manage patients who appear to be nonresponders. Simple advice and minor adjustments to medical therapy are usually all that is needed for most patients, but in some, management requires knowledge of the principles outlined in this article. If followed, only a small group of patients should be medically refractory.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695005     DOI: 10.1016/s0889-8553(05)70093-5

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  7 in total

Review 1.  Practical approaches to dysphagia caused by esophageal motor disorders.

Authors:  A S Arora; J L Conklin
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Effect of CYP2C19 genotypes on the pharmacokinetic/pharmacodynamic relationship of rabeprazole after a single oral dose in healthy Chinese volunteers.

Authors:  Yu-Cheng Sheng; Kun Wang; Ying-Chun He; Juan Yang; Qing-Shan Zheng
Journal:  Eur J Clin Pharmacol       Date:  2010-09-14       Impact factor: 2.953

3.  Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese.

Authors:  Mitsushige Sugimoto; Naohito Shirai; Masafumi Nishino; Chise Kodaira; Takahiro Uotani; Shu Sahara; Hitomi Ichikawa; Takuma Kagami; Ken Sugimoto; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2014-07-06       Impact factor: 2.953

4.  Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.

Authors:  Joel E Richter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-09

Review 5.  The pharmacology and clinical relevance of proton pump inhibitors.

Authors:  Philip O Katz; Christine Frissora
Journal:  Curr Gastroenterol Rep       Date:  2002-12

6.  Analysis on the causes for refractory GERD.

Authors:  Jie Chen; Junying Xu; Yong Xu; Xiaoping Xie; Cuiqiong Yi; Xiaohua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

7.  Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.

Authors:  Dolores Ochoa; Manuel Román; Teresa Cabaleiro; Miriam Saiz-Rodríguez; Gina Mejía; Francisco Abad-Santos
Journal:  BMC Pharmacol Toxicol       Date:  2020-07-25       Impact factor: 2.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.